Nanoparticle-based contrast agents are designed to accumulate in specific tissues or cells. These nanoparticles can be functionalized with targeting molecules that bind to biomarkers expressed by diseased cells. When introduced into the body, they provide enhanced contrast in MRI scans, allowing for better visualization of abnormalities.
